Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Get started with wealth management for beginners in 2023. Learn the basics to build a solid financial foundation today!
18,336 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
A hypothetical turn of events places Kevin Warsh at the Fed helm, where rate cuts look unlikely as inflation remains ...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
SpaceX going public $1.8 trillion would be the biggest IPO in history. This guide explains what that means for everyd...
As AI workloads push memory demand higher, micron stock could have substantial upside. Yet a high-capex Virginia expa...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
When billionaire Dalio just warned about AI hype, it sparked a wider discussion on valuations and risk. This guide ex...
Adobe is expected to announce its next chief executive on Thursday, with the board leaning toward an internal candida...
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
A sharp job split shows healthcare added about 900,000 positions while other sectors shed jobs. Investors are reasses...
Oklo has faced a challenging six months as the stock trended lower with little revenue to show. This article explores...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...